Video-Feedback Interaction Guidance for Postpartum Depression
(VID-KIDS Trial)
Trial Summary
What is the purpose of this trial?
Postpartum depression (PPD) is a major public health issue. Known as "the thief that steals motherhood" since symptoms obstruct a mother's capacity for understanding and enjoying her baby, PPD affects approximately 1 in 5 moms. Built via "serve and return" interactions (e.g. baby smiles, mom smiles back), sensitive and responsive exchanges are the foundation for healthy child development but are diminished by PPD, resulting in interactions that place children at risk for behavioural and cognitive problems. Infants perceive PPD as stressful; stressors stimulate the brain's hypothalamic pituitary adrenal axis (HPA) and trigger stress hormone (cortisol) release, which, in turn, negatively affects developing infant brains by decreasing brain volume. Infants' critical periods of brain development are vulnerable to long-term effects of cortisol, explaining some of the problematic developmental outcomes observed in children of depressed mothers. How can the investigators support depressed mothers and their infants? Successfully treating PPD does not always benefit mother-child relationships; however, this research builds on a successful pilot that demonstrated that nurse-guided video feedback improved mother-infant interactions in the context of PPD. By improving interaction quality, depressed mothers may be motivated to engage in more play and, in turn, infants who appear interested and ready to interact are more likely to elicit positive, enjoyable experiences from mothers. Building on the pilot, the investigators will trial the effectiveness of VID-KIDS (Video-Feedback Interaction Guidance for Improving Interactions Between Depressed Mothers and their Infants) on maternal-infant interaction and infant cortisol patterns as well as infant development, maternal symptoms of depression and anxiety, and parenting self-efficacy. If successful, future aims are to 1) integrate VID-KIDS into existing services of Calgary Public Health; and 2) commercialize VID-KIDS for dissemination.
Will I have to stop taking my current medications?
The trial does not require you to stop taking your current medications, including anti-depressants or other interventions for postpartum depression.
What data supports the effectiveness of the VID-KIDS Intervention Program treatment for postpartum depression?
Research shows that interactive coaching interventions can help improve the connection between mothers with postpartum depression and their babies, which is similar to the goals of the VID-KIDS program. Additionally, various psychosocial and psychological interventions have been found effective in reducing postpartum depression, suggesting that similar approaches like VID-KIDS could also be beneficial.12345
How is the VID-KIDS Intervention Program treatment different from other treatments for postpartum depression?
The VID-KIDS Intervention Program is unique because it uses video feedback to help mothers with postpartum depression improve their interactions with their babies. This approach allows mothers to see and reflect on their behavior, which can help change their self-image and enhance their parenting skills, unlike traditional treatments that may not use visual feedback.16789
Research Team
Nicole L Letourneau, RN, PhD
Principal Investigator
University of Calgary
Eligibility Criteria
This trial is for mothers with postpartum depression, indicated by a score greater than 12 on the Edinburgh Postnatal Depression Scale, and who have infants aged 2-6 months. Mothers taking antidepressants or undergoing other PPD treatments can join, but not those receiving certain other parenting services.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial assessment of mothers and infants before intervention begins
Treatment
Mothers receive 3 video-feedback sessions during home visits at 3-week intervals
Post-test Assessment
Assessment immediately following the 9-week treatment/standard care interval
Follow-up
Participants are monitored for changes in mother-infant interactions and infant cortisol patterns
Treatment Details
Interventions
- VID-KIDS Intervention Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Calgary
Lead Sponsor
Alberta Health services
Collaborator